Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022011323 - OCULAR DISEASE TREATMENT USING ANTI-TISSUE FACTOR ANTIBODIES

Publication Number WO/2022/011323
Publication Date 13.01.2022
International Application No. PCT/US2021/041191
International Filing Date 10.07.2021
IPC
C07K 16/24 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
24against cytokines, lymphokines or interferons
Applicants
  • ICONIC THERAPEUTICS, INC. [US]/[US]
Inventors
  • GAUDREAULT, Jacques
  • BURIAN, Gabriela
  • MIGONE, Thi-Sau
  • GREENE, William
Agents
  • MUBYANA, Kuwabo
  • SHUSTER, Michael J.
  • KABLER, Kevin
  • HURT, Nicholas
  • ZHANG, Clark
  • RODRIGUEZ, Elena M.
  • WIENS, Mayim E.
  • NEWMAN, Zachary R.
Priority Data
63/050,64310.07.2020US
63/182,69630.04.2021US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) OCULAR DISEASE TREATMENT USING ANTI-TISSUE FACTOR ANTIBODIES
(FR) TRAITEMENT DE MALADIE OCULAIRE À L'AIDE D'ANTICORPS ANTI-FACTEUR TISSULAIRE
Abstract
(EN) Provided herein are antibodies that specifically bind to human tissue factor (TF) and are useful for the treatment of ocular diseases. Also provided herein are methods of treating subjects having ocular diseases by administering the anti-TF antibodies.
(FR) L'invention concerne des anticorps qui se lient spécifiquement au facteur tissulaire (TF) humain et qui sont utiles pour le traitement de maladies oculaires. L'invention concerne également des méthodes de traitement de sujets atteints de maladies oculaires par administration des anticorps anti-TF.
Latest bibliographic data on file with the International Bureau